PubRank

Chin Hur

Author PubWeight™ 34.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol 2006 2.88
2 Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol 2008 2.74
3 Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 2013 2.13
4 A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology 2012 1.58
5 Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med 2012 1.52
6 Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. Dig Dis Sci 2014 1.44
7 Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol 2008 1.42
8 Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol 2012 1.09
9 Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology 2008 1.04
10 Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer 2010 1.01
11 Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival. Gastrointest Endosc 2010 1.00
12 Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus. Gastroenterology 2013 0.97
13 Development of an empirically calibrated model of gastric cancer in two high-risk countries. Cancer Epidemiol Biomarkers Prev 2008 0.95
14 Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis 2013 0.93
15 Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model. PLoS Med 2013 0.92
16 The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev 2011 0.91
17 Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Radiology 2014 0.88
18 Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci 2009 0.87
19 Screening and surveillance for Barrett's esophagus: current issues and future directions. Curr Opin Gastroenterol 2012 0.87
20 Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci 2011 0.86
21 Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol 2005 0.84
22 Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis. Dig Dis Sci 2008 0.84
23 Microsatellite instability is frequently observed in rectal cancer and influenced by neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys 2007 0.82
24 Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol 2011 0.81
25 Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population. AJR Am J Roentgenol 2010 0.79
26 Secular trends in patients diagnosed with Barrett's esophagus. Dig Dis Sci 2009 0.79
27 What is the clinical importance of small polyps with regard to colorectal cancer screening? Nat Clin Pract Gastroenterol Hepatol 2006 0.78
28 Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. Cancer Prev Res (Phila) 2013 0.77
29 Responsiveness of the testing morbidities index in colonoscopy. Value Health 2013 0.77
30 Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow? Clin Gastroenterol Hepatol 2007 0.76
31 Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 2009 0.75
32 How to value technological innovation: a proposal for determining relative clinical value. Gastroenterology 2012 0.75
33 Targeted Screening of Individuals at High Risk for Pancreatic Cancer: Results of a Simulation Model. Radiology 2016 0.75